SCHEMBL1619230

SCHEMBL1619230

O=C(/C=C/c1cccc(OC(F)(F)C(F)F)c1)c1c(Br)cccc1[N+](=O)[O-]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
MAOA P21397 3/20 0.44
COMT P21964 2/20 0.44
MAPT P10636 6/20 0.42
LMNA P02545 3/20 0.42
HSP90AA1 P07900 1/20 0.42
ATM Q13315 1/20 0.42
MAOB P27338 4/20 0.41
TXNRD1 Q16881 1/20 0.41
TXNRD3 Q86VQ6 1/20 0.41
TXNRD2 Q9NNW7 1/20 0.41
CETP P11597 1/20 0.39
PAX8 Q06710 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.37
FBP1 P09467 1/20 0.37
USP2 O75604 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4749788 1.00 ALDH1A1 (0.45) ALDH1A1MAOACOMTMAPTLMNA
SCHEMBL1619231 0.80 MAPT (0.42) ALDH1A1MAOACOMTMAPTLMNA
SCHEMBL25190822 0.73 P4HB (0.62) MAOAMAPTMAOBMEN1KMT2A
SCHEMBL25206648 0.70 ABCG2 (0.67) ALDH1A1MAOAMAPTLMNAHSP90AA1
SCHEMBL4753149 0.70 MEN1 (0.44) ALDH1A1MAPTLMNACETPSMN1; SMN2
SCHEMBL9190260 0.66 TSHR (0.50) ALDH1A1MAPTLMNAHSP90AA1CETP
SCHEMBL896842 0.66 PIM1 (0.56) ALDH1A1MAOAMAPTMAOBPIM1
SCHEMBL28269250 0.65 CYP1B1 (0.51) ALDH1A1MAOACOMTMAPTLMNA
SCHEMBL25192708 0.65 SLC5A1 (0.54) ALDH1A1MAOACOMTMAPTMAOB
SCHEMBL25265254 0.65 SLC5A1 (0.54) ALDH1A1MAOACOMTMAPTMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7928238-B2 1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors JANSSEN PHARMACEUTICA NV (BE) 2011-04-19 US disclosed